The MIF Antagonist IV, RDR 03785 controls the biological activity of MIF. This small molecule/inhibitor is primarily used for Cell Structure applications.

Isorhamnetin 3-O-α-L-arabinoside-7- O-α-L-rhamnoside

Tert-butyl 6-hydroxyhexanoate (BHH) is an initiator for the preparation of α-tert-butyloxycarbonylω-hydroxyheterobifunctional poly(ε-caprolactone) (PCL) and poly(δ-valerolactone) PVL.